
|Articles|July 8, 2019
PHARMASEAL Launches Second Release of Engility CTMS
Advertisement
PHARMASEAL has announced a second major release of its Engility CTMS platform with new features like site monitoring and global access management.
Find out more about the new features
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5



